An update on chemoprevention strategies in prostate cancer for 2006

Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

2005 • 2,499 citations

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

2005 • 2,476 citations

Lycopene as the most efficient biological carotenoid singlet oxygen quencher

1989 • 2,238 citations

The Influence of Finasteride on the Development of Prostate Cancer

2021 • 2,078 citations

Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

2005 • 2,039 citations

Androgen Receptor in Prostate Cancer

2004 • 1,679 citations

Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer

1995 • 1,356 citations

Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer

2005 • 1,160 citations

Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

2003 • 1,035 citations

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

2003 • 521 citations

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

2000 • 521 citations

The Role of Tomato Products and Lycopene in the Prevention of Prostate Cancer: A Meta-Analysis of Observational Studies

2004 • 436 citations

Incidence of Cancer and Mortality Following α-Tocopherol and β-Carotene Supplementation

2003 • 423 citations

In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.

2000 • 416 citations

Bioavailability of all-trans and cis–Isomers of Lycopene

2002 • 360 citations

Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells

2003 • 317 citations

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

2001 • 311 citations

Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer

2004 • 296 citations

Statin use and cancer risk in the General Practice Research Database

2004 • 245 citations

Epidemiology of Inflammation and Prostate Cancer

2004 • 241 citations

Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate Cancer

2005 • 233 citations

Statins and Prostate Cancer Risk: A Case-Control Study

2005 • 231 citations

Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells

2004 • 199 citations

Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study

2004 • 185 citations

A Large Cohort Study of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer Incidence

2005 • 184 citations

Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model

2004 • 179 citations

Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.

2002 • 174 citations

Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis

2004 • 172 citations

Androgens, lipogenesis and prostate cancer

2004 • 171 citations

Lycopene Inhibits the Growth of Human Androgen-Independent Prostate Cancer Cells In Vitro and in BALB/c Nude Mice

2005 • 166 citations

E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.

2000 • 162 citations

Meta-analysis of soy food and risk of prostate cancer in men

2005 • 142 citations

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis

1999 • 132 citations

Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies

2004 • 131 citations

PREVALENCE AND PATTERNS OF THE USE OF COMPLEMENTARY THERAPIES AMONG PROSTATE CANCER PATIENTS: AN EPIDEMIOLOGICAL ANALYSIS

1999 • 126 citations

Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery

2003 • 122 citations

Antioxidants Block Prostate Cancer in Lady Transgenic Mice

2004 • 121 citations

Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model

2004 • 120 citations

Physiologically Attainable Concentrations of Lycopene Induce Mitochondrial Apoptosis in LNCaP Human Prostate Cancer Cells

2005 • 118 citations

Non‐steroidal anti‐inflammatory drugs for the prevention and treatment of cancer

2005 • 113 citations

Dietary Fat and Prostate Cancer

2004 • 110 citations

The Selenium and Vitamin E Cancer Prevention Trial

2003 • 103 citations

Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale

2004 • 98 citations

The role of soy phytoestrogens in prostate cancer

2004 • 93 citations

Histopathological effects of androgen deprivation in prostatic cancer.

1996 • 84 citations

p21-dependent Inhibition of Colon Cancer Cell Growth by Mevastatin Is Independent of Inhibition of G1 Cyclin-dependent Kinases

2003 • 84 citations

Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate

2004 • 77 citations

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer

2005 • 75 citations

Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.

2004 • 71 citations

Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells

2005 • 70 citations

Inverse Association between Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer

2004 • 67 citations

Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk

2003 • 63 citations

THE EFFECTS OF 5α-REDUCTASE INHIBITORS ON THE NATURAL HISTORY, DETECTION AND GRADING OF PROSTATE CANCER: CURRENT STATE OF KNOWLEDGE

2005 • 60 citations

Frequent Use of Complementary Medicine by Prostate Cancer Patients

2003 • 59 citations

NITRIC OXIDE DONATING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS INDUCE APOPTOSIS IN HUMAN PROSTATE CANCER CELL SYSTEMS AND HUMAN PROSTATIC STROMA VIA CASPASE-3

2004 • 56 citations

Synergistic effect of vitamin E and selenium in human prostate cancer cell lines

2004 • 55 citations

Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia

2003 • 54 citations

Prostate carcinoma and green tea: (−)epigallocatechin‐3‐gallate inhibits inflammation‐triggered MMP‐2 activation and invasion in murine TRAMP model

2004 • 53 citations

Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells.

2003 • 49 citations

Lycopene Effects on Rat Normal Prostate and Prostate Tumor Tissue

2005 • 36 citations

Chemoprevention using dutasteride: the REDUCE trial

2004 • 36 citations

Estimated impact of the Prostate Cancer Prevention Trial on population mortality

2005 • 33 citations

Nitrosulindac (NCX 1102): A new nitric oxide‐donating non‐steroidal anti‐inflammatory drug (NO‐NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines

2004 • 29 citations

Prevalence and patterns of self‐initiated nutritional supplementation in men at high risk of prostate cancer

2004 • 21 citations

Clinical Trials Point to Complexities of Chemoprevention for Cancer

2005 • 15 citations

1664: Pathological Assessment of High Grade Tumors in the Prostate Cancer Prevention Trial (PCPT)

2005 • 10 citations